Gifford-Truhlsen Conference Keynote Presentations

Gifford-Truhlsen Conference Keynote Presentations

The Annual Gifford-Truhlsen Conference: Current Concepts in Ophthalmology and Visual Sciences was not held in 2020 due to COVID-19. So, the June 2021 conference included keynote lectures from the 2020 and 2021 conferences. These presentations have been grouped into four separate modules – for a total of ten presentations by eight distinguished lecturers:

  1. Harold Gifford, Jr., MD Keynote Presentations Module

    • The Evolution of Keratoplasty: A Complete Paradigm Change in the Last Quarter Century
    • New Innovations in the Management of Neurotrophic Keratopathy
      — Bennie H. Jeng, MD, University of Maryland School of Medicine
    • Anti-VEGF and Beyond: The Past, Present, and Future of Treatment for Neovascular AMD
      — Paul Sternberg, Jr., MD, Vanderbilt University Medical Center
  2. Stanley M. Truhlsen, MD Keynote Presentations Module

    • Long Term Treatment Outcomes in Neovascular AMD: What We Know and What We Don't
    • Top 5 Findings from DRCR Retina Network Clinical Trials
      — Daniel Martin, MD, Cleveland Clinic Cole Eye Institute
    • Intraocular Tumors: Accomplishments and a Look Into the Future
      — Carol L. Shields, MD, Thomas Jefferson University
  3. Charles Fritch, MD Keynote Presentations Module

    • Lessons Learned
      — Randall J. Olson, MD, University of Utah School of Medicine
    • Advances in Corneal Neurotization
      — Steven M. Couch, MD, Washington University School of Medicine
  4. Bernstein-Kroon Presentations Module

    • Genetic and Epigenetic Control of Photoreceptor Development: Implications for Designing Therapies of Retinal Diseases
      — Anand Swaroop, PhD, National Institutes of Health
    • Personalized Wavefront-Guided Vision Correction and Corneal Biomechanics
      — Geunyoung Yoon, PhD, University of Rochester

Target Audience

These enduring material modules are intended for ophthalmologists, optometrists, residents, medical students, fellows, vision research scientists, and other eye care professionals and technicians who were NOT able to participate in the Annual Gifford-Truhlsen Conference: Current Concepts in Ophthalmology and Visual Sciences (two-day virtual conference) held June 11-12, 2021.


Accreditation

JA Provider MarkIn support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Term of Approval

Release Date: August 30, 2021
Expiration Date: August 30, 2022


Support

The Gifford Truhlsen Conference Keynote Presentations is supported by unrestricted grants from Alcon Vision, Inc; Genentech; and Regeneron Medical Education.


How to Access the Modules and Receive Continuing Education Credit

Questions

If you have questions about these modules, please contact Jackie Farley via email.


Available Modules

Harold Gifford, Jr., MD Keynote Presentations Module  

The Harold Gifford, Jr., MD Keynote Lecturers

  • 2020 — Bennie H. Jeng, MD 
    Professor and Chair, Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD
  • 2021 — Paul Sternberg, Jr., MD
    G. W. Hale Professor and Chair, Vanderbilt Eye Institute; Chief Medical Officer, Vanderbilt Medical Group; Chief Patient Experience Officer, Vanderbilt University Medical Center; Associate Dean for Clinical Affairs, Vanderbilt School of Medicine, Nashville, TN

Learning Objectives

Upon completion of this enduring material module, the participant should be better able to:

The Evolution of Keratoplasty: A Complete Paradigm Change in the Last Quarter Century (Jeng)

1. Describe the evolution of keratoplasty
2. Explain indications of keratoplasty

New Innovations in the Management of Neurotrophic Keratopathy (Jeng)

3. Discuss the challenges of neurotrophic keratopathy
4. State the therapies for neurotrophic keratopathy

Anti-VEGF and Beyond:  The Past, Present, and Future of  Treatment for Neovascular AMD (Sternberg)

5. Explain the impact of the introduction of anti-VEGF therapy on the management of AMD patients
6. Review the various strategies for the use of anti-VEGF agents, and the pros and cons from the perspectives of outcomes, complications, cost, and treatment burden
7. Describe potential future therapies and how they can help advance outcomes

Continuing Education Credit

JA Provider MarkIn support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Nebraska Medical Center designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Approval

Release Date: August 30, 2021
Expiration Date: August 30, 2022

Faculty and Planning Committee Disclosures

Disclosure Declaration (PDF)

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:

FACULTY

  • Bennie H. Jeng, MD
    Consultant: GlaxoSmithKline, Merck, Santen, Sanofi
    Owner/Consultant: EyeGate
  • Paul Sternberg, Jr., MD
    Off-label: Bevacizumab, use for treatment of neovascular AMD

PLANNING COMMITTEE

  • Rao Chundury, MD
    Speaker's Bureau: Horixona Medical

The following planning committee members have nothing to disclose:

  • David Anderson, MD
  • Colby Argo, MD
  • David Clark, MHA
  • Jackie Farley
  • Kim Kanellis, BS
  • Ronald Krueger, MD
  • Matthew Van Hook, PhD

Register Now

 

Stanley M. Truhlsen, MD Keynote Presentations Module  

The Stanley M. Truhlsen, MD Keynote Lecturers

  • 2020 — Daniel Martin, MD 
    Chair, Cleveland Clinic Cole Eye Institute, Cleveland, OH
  • 2021 — Carol L. Shields, MD
    Chief, Ocular Oncology Service, Wills Eye Hospital; Professor of Ophthalmology, Thomas Jefferson University, Philadelphia, PA

Learning Objectives

Upon completion of this enduring material module, the participant should be better able to:

Long Term Treatment Outcomes in Neovascular AMD: What We Know and What We Don't (Martin)

1. Discuss injection frequency pros and cons

Top 5 Findings from DRCR Retina Network Clinical Trials (Martin)

2. Discuss treatment protocols

Intraocular Tumors: Accomplishments and a Look Into the Future (Shields)

3. Describe the key protocols for prevention of intraocular tumors
4. Discuss treatment options for intraocular tumors
5. Share an example of how to play offense instead of defense in preventing cancer in the future

Continuing Education Credit

JA Provider MarkIn support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Nebraska Medical Center designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Approval

Release Date: August 30, 2021
Expiration Date: August 30, 2022

Faculty and Planning Committee Disclosures

Disclosure Declaration (PDF)

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:

FACULTY

  • Carol L. Shields, MD
    Consultant: AURA Biosciences

PLANNING COMMITTEE

  • Rao Chundury, MD
    Speaker's Bureau: Horixona Medical

FACULTY

The following faculty member has nothing to disclose:

  • Daniel Martin, MD

PLANNING COMMITTEE

The following planning committee members have nothing to disclose:

  • David Anderson, MD
  • Colby Argo, MD
  • David Clark, MHA
  • Jackie Farley
  • Kim Kanellis, BS
  • Ronald Krueger, MD
  • Matthew Van Hook, PhD

Register Now

 

Charles Fritch, MD Keynote Presentations Module  

The Charles Fritch, MD Keynote Lecturers

  • 2020 — Randall J. Olson, MD 
    Professor and Chair, Department of Ophthalmology and Visual Sciences; CEO, John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT
  • 2021 — Steven M. Couch, MD 
    Associate Professor, Department of Ophthalmology & Visual Sciences; Director of Quality and Safety, Washington University School of Medicine, St. Louis, MO

Learning Objectives

Upon completion of this enduring material module, the participant should be better able to:

Lessons Learned (Olson)

1. Define the most common failures in advancing science-based medical knowledge
2. Define principles of adding knowledge to our skillset that minimizes the impact of these common failings in the rapidly evolving field of ophthalmology
3. Research how this can help in our overall work/life balance, especially in this era of widespread burn-out

Advances in Corneal Neurotization (Couch)

4. Define clinical features of neurotrophic keratitis
5. Review surgical approaches to corneal neurotization
6. Describe clinical approach and outcomes of corneal neurotization

Continuing Education Credit

JA Provider MarkIn support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Nebraska Medical Center designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Approval

Release Date: August 30, 2021
Expiration Date: August 30, 2022

Faculty and Planning Committee Disclosures

Disclosure Declaration (PDF)

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:

FACULTY

  • Randall J. Olson, MD
    Medical Advisory Board/Shareholder: Perfect Lens
    Shareholder: EyeGate
    Board of Directors/Shareholder: Voyant Biotherapeutics

PLANNING COMMITTEE

  • Rao Chundury, MD
    Speaker's Bureau: Horixona Medical

FACULTY

The following faculty member has nothing to disclose:

  • Steven M Couch, MD
PLANNING COMMITTEE

The following planning committee members have nothing to disclose:

  • David Anderson, MD
  • Colby Argo, MD
  • David Clark, MHA
  • Jackie Farley
  • Kim Kanellis, BS
  • Ronald Krueger, MD
  • Matthew Van Hook, PhD

Register Now

 

Bernstein-Kroon Presentations Module  

The Bernstein-Kroon Keynote Lecturers

  • 2020 — Anand Swaroop, PhD 
    Senior Investigator and Chief, Neurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institute of Health, Bethesda, MD
  • 2021 — Geunyoung Yoon, PhD 
    Professor, Department of Ophthalmology, The Institute of Optics, Center for Visual Science, Department of Biomedical Engineering, University of Rochester, Monroe County, NY

Learning Objectives

Upon completion of this enduring material module, the participant should be better able to:

Genetic and Epigenetic Control of Photoreceptor Development: Implications for Designing Therapies of Retinal Diseases (Swaroop)

1. Discuss current studies on genetic and epigenetic control mechanisms
2. Describe photoreceptor development

Personalized Wavefront-Guided Vision Correction and Corneal Biomechanics (Yoon)

3. Describe the inversion table
4. Explain how to enhance focus performance

Continuing Education Credit

JA Provider MarkIn support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Nebraska Medical Center designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Approval

Release Date: August 30, 2021
Expiration Date: August 30, 2022

Faculty and Planning Committee Disclosures

Disclosure Declaration (PDF)

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:

FACULTY

  • Anand Swaroop, PhD
    Consultant: GlaxoSmithKline 
    Owner/Consultant: EyeGate
  • Geunyoung Yoon, PhD
    Consultant: Coopervision
    Stockholder/Consultant: Ovitz
    Consultant/Researcher: Johnson & Johnson, Bausch Health

PLANNING COMMITTEE

  • Rao Chundury, MD
    Speaker's Bureau: Horixona Medical

The following planning committee members have nothing to disclose:

  • David Anderson, MD
  • Colby Argo, MD
  • David Clark, MHA
  • Jackie Farley
  • Kim Kanellis, BS
  • Ronald Krueger, MD
  • Matthew Van Hook, PhD

Register Now